Drawing for MAKE EYECARE SELFCARE

USPTO serial 99582476

MAKE EYECARE SELFCARE

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
LORENZO, KATHLEEN H
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAKE EYECARE SELFCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas J. Perkowski

Thomas J. Perkowski Thomas J. Perkowski, ESQ. PC6 Thorndal CircleSecond FloorDarien CT, CT 06820-5415

Goods and services

ClassDescriptionStatusFirst use
003Preparations for cleaning the eyes and eyelids, namely, eye-washes not for medical purposes; eye cleaner, namely, eye cleansing hygienic wipes impregnated with cleansing solution; eye compresses for cosmetic purposes, namely, non-microwaveable warm eye compresses, hydro-gel eye masks and eye masks; Non-medicated skin care preparations, namely, non-refrigerated cooling eye mask, and eye masks impregnated with skin moisturizer or beneficial skin preparationACTIVE—
005Vitamins, dietary and nutritional supplements that promote ocular health; ophthalmic preparations and substances for the provision of optimum eye function; multivitamin preparations, namely, multivitamin preparations for promoting retinal health; multivitamin preparations, namely, multivitamin preparations for promoting general health and eye health; food supplements, namely, anti-oxidants for promoting optimal tear film supplementation, osmolarity and stability; nutritional supplements comprising vitamins, antioxidants and fatty acids for promoting optimal tear film supplementation, osmolarity and stability; Artificial tears, namely, preservative free artificial tears; Artificial tears, namely, artificial tears for the provision of ocular surface lubrication; Artificial tears, namely, artificial tears in gel, ointment and drop form for the provision of ocular surface lubricationACTIVE—
009downloadable movies and digital content concerning eye health, disease prevention and treatment, and eyecare; Downloadable computer software systems for providing computer programs and services to others involving providing educational services via an online portal and community portal to promote ocular health, disease treatment and prevention; Downloadable computer software systems for providing computer programs and services to others involving providing virtual consultation services to patients relating to the diagnosis and treatment of ocular conditions in humans, including Dry Eye Disease (DED); Computer hardware and downloadable computer software in the field of remote patient eyecare support and delivery, for the support and delivery of AI-assisted diagnosis, prescription, treatment, compliance and management services to patientsACTIVE—
016Paper books, magazines and printed publications, namely, brochures, booklets, and workbooks concerning eye health, disease prevention and treatment, and eyecare; printed educational materials, educational publications, and educational booklets concerning ocular health, disease treatment and prevention, and eyecare; Printed materials pertaining to patient eyecare, namely, press releases, pamphlets, brochures, newsletters, books, posters, periodicals, calendars, magazines, printed instructional, educational and teaching material, paper banners, envelopes, cardboard boxes and packages, shipping and address labels, stationery, pen and pencil sets, pens, note holders, fountain pens, business card files, packing paper, packaging tape, cardboard, cardboard envelopes and cartons; plastic bags and envelopes and pouches for packaging; plastic bubble packs for wrapping or packagingACTIVE—
035Retail store services featuring eyecare products, supplies and services and a variety of consumer goods relating to eyecare; providing consumer product information via the internet or other communications networks; administration of customer loyalty program services which enable participants to obtain discounts on eyecare goods and services, discounted shipping, expedited shipping and early access to sales events; customer loyalty program services featuring rewards in the form of discounted shipping services; administration services for discount programs enabling participants to obtain discounts on eyecare related goods and services, discounted shipping, expedited shipping and early access to sales events; information services, namely, providing information about retail products for promoting eyecare to customersACTIVE—
042Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others, involving providing virtual consultation services to others relating to ocular health, disease treatment and prevention; Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others, involving the ordering and delivery of products promoting ocular health, disease treatment and prevention; Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others, involving educational services via an online portal and community portal; Providing web-based and cloud-based systems, online portals and system networks featuring technology that enables users to receive remote patient eyecare services including AI-assisted diagnosis, prescription, treatment, compliance and management of ocular diseases (OD) in humans, including Dry Eye Disease (DED); Providing a web-based system and online portals featuring technology that enables users to receive remote patient eyecare services, including eyecare diagnosis, treatment, compliance and managementACTIVE—
044Providing a web-based system and online portals for eyecare diagnosis, treatment, patient compliance and patient management; Providing web-based and cloud-based systems and online portals for remote patient eyecare services including AI-assisted diagnosis, prescription, treatment, patient compliance and patient management of ocular diseases (OD) in humans, including Dry Eye Disease (DED)ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 20, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 20, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 11, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2026DOCKASSIGNED TO EXAMINER—
Apr 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance